DOI: 10.1055/s-00000077

Seminars in Thrombosis and Hemostasis

Ausgabe 07 · Volume 33 · Oktober 2007 DOI: 10.1055/s-002-7329 Inhibitors of Hemostatic System in Cancer: Basic and Clinical Aspects Guest Editors, Marek Z. Wojtukiewicz, M.D., and Ewa Sierko, M.D.

Erratum

  • e1
    Amirkhosravi, Ali; Meyer, Todd; Amaya, Mildred; Davila, Monica; Mousa, Shaker A.; Robson, Theresa; Francis, John L.:

    Erratum: The Role of Tissue Factor Pathway Inhibitor in Tumor Growth and Metastasis

  • PREFACE

  • 619
  • 621
    Wojtukiewicz, Marek Z.; Sierko, Ewa; Kisiel, Walter:

    The Role of Hemostatic System Inhibitors in Malignancy

  • 653
    Sierko, Ewa; Wojtukiewicz, Marek Z.; Kisiel, Walter:

    The Role of Tissue Factor Pathway Inhibitor-2 in Cancer Biology

  • 660
  • 667
  • 673
    Hanly, Ann M.; Winter, Desmond C.:

    The Role of Thrombomodulin in Malignancy

  • 680
  • 688
  • 695
  • 699
  • 707
  • 712
  • Review Article

  • 643
    Amirkhosravi, Ali; Meyer, Todd; Amaya, Mildred; Davila, Monica; Mousa, Shaker A.; Robson, Theresa; Francis, John L.:

    The Role of Tissue Factor Pathway Inhibitor in Tumor Growth and Metastasis